3 news items
Aurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024
AUPH
5 Jun 24
for developing malignancies and serious infections with LUPKYNIS or other immunosuppressants that may lead to hospitalization or death
Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation's Spring Clinical Meeting 2024
AUPH
14 May 24
and serious infections with LUPKYNIS or other immunosuppressants that may lead to hospitalization or death
Aurinia Presents Data Reinforcing LUPKYNIS® Safety and Efficacy for People with Lupus Nephritis at Congress of Clinical Rheumatology East 2024
AUPH
9 May 24
that may lead to hospitalization or death.
CONTRAINDICATIONS
- Prev
- 1
- Next